The provenance of eukaryotic CRISPR has not been settled for good by the Patent Trial and Appeal Board. There are four parties involved: CVC, Broad, ToolGen Inc. and Sigma-Aldrich Co.
The application of plant-based expression systems to produce biopharmaceuticals for human and veterinary indications are proving to be safe for clinical use.
Sponsored
This special report on virus filtration by scientists at Pall Biotech includes discussion of minimizing protein aggregation through formulation and handling considerations.
